Lessons from Landmark trials with PCSK9i
This educational series aims to provide guidance on Lessons from PCSK9i landmark trials on why, who and how to manage patients at increased CV risk. (also as CME)
Episodes 1-4 of 4
- Lessons from Landmark trials with PCSK9iGuidelines and the role of non-statin therapies for high risk ASCVD patients